Explore / oncology
0 explorers / 0 open questions / 0 papers
Layered concept explanation pending live version data.
Known nodes connect to ghost nodes where questions remain open.
Credit follows documented contributions. Open questions remain attached to the historical path rather than being presented as context-free prompts.
Open questions
Which tumour-microenvironment mechanisms are most responsible for treatment resistance and can be measured in patients?
0 researchers / 0 stakes
Open research workspace
Which biomarker combinations can detect pancreatic cancer early enough to improve outcomes in a defined high-risk population?
0 researchers / 0 stakes
Open research workspace
How should high-risk cohorts be selected so screening benefit exceeds false-positive harm?
0 researchers / 0 stakes
Open research workspace
Ghost nodes
How should high-risk cohorts be selected so screening benefit exceeds false-positive harm?
US National Cancer Institute / 0 active
openWhich biomarker combinations can detect pancreatic cancer early enough to improve outcomes in a defined high-risk population?
US National Cancer Institute / 0 active
openWhich tumour-microenvironment mechanisms are most responsible for treatment resistance and can be measured in patients?
US National Cancer Institute / 0 active